DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr.

2017 年 10 月 18 日 7:00 上午 - 2017 年 10 月 19 日 10:00 下午

1750 Rockville Pike, , Rockville, MD 20852 , USA

Metrics in Patient-Centered Drug Development Conference

Session 8: The Emerging Role of the Patient in an Evolving Health Ecosystem

Session Chair(s)

Marc M. Boutin, JD

Marc M. Boutin, JD

Global Head of Patient Engagement and Advocacy

Novartis , Switzerland

Patients are demanding a more meaningful role in all aspects of our health care ecosystem. In addition to a greater emphasis on patient involvement, emerging science, technology, value, and costs will disrupt health systems creating opportunities to re-envision how we promote, protect, and restore health and well-being. The downstream implications make patient-centered drug development a competitive necessity now and will intensify in the coming years.

Learning Objective :
  • Identity specific areas where patients will play an increasing role in the health care ecosystem
  • Articulate how emerging disruptions could impact future health systems
  • Identity a range of future health system scenarios and their respective impact on patient-centered drug development
  • Speaker(s)

    Kelly  Brantley

    Speaker

    Kelly Brantley

    Avalere Health, United States

    Vice President

    David  Weinstock

    Speaker

    David Weinstock

    Dana-Farber Cancer Institute and Harvard Medical School, United States

    Associate Professor of Medicine

    Lode  Dewulf

    Speaker

    Lode Dewulf

    Corvalus, Belgium

    Patient and Medical Affairs Consultant

    Michael  Goettler

    Speaker

    Michael Goettler

    Pfizer, Inc., United States

    Global President, Rare Disease

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。